FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24
In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced
DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program
FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA
NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









